Update shared on04 Oct 2025
Fair value Increased 8.55%Analysts have raised their price target for SiriusPoint from $25.33 to $27.50. This reflects a more optimistic outlook based on slightly higher projected revenue growth and modest adjustments in key valuation metrics.
What's in the News
- SiriusPoint completed its share buyback program, having repurchased a total of 24,028,795 shares. This represents 19.97% of shares outstanding, for $316.95 million since the program began in May 2016 (Key Developments).
- Between April 1 and June 30, 2025, no additional shares were repurchased. This marks the official end of the buyback tranche (Key Developments).
Valuation Changes
- The consensus analyst price target has increased from $25.33 to $27.50, reflecting a more optimistic fair value assessment.
- The discount rate has edged up slightly from 6.86% to 6.91%.
- The revenue growth projection has risen from 7.64% to 8.64%.
- The net profit margin estimate has decreased modestly from 11.56% to 11.25%.
- The future P/E ratio has increased from 7.14x to 7.76x, indicating higher anticipated earnings multiples.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.